495 related articles for article (PubMed ID: 26439639)
1. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Gautier HO; Evans KA; Volbracht K; James R; Sitnikov S; Lundgaard I; James F; Lao-Peregrin C; Reynolds R; Franklin RJ; Káradóttir RT
Nat Commun; 2015 Oct; 6():8518. PubMed ID: 26439639
[TBL] [Abstract][Full Text] [Related]
2. Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.
Harlow DE; Saul KE; Komuro H; Macklin WB
J Neurosci; 2015 Aug; 35(34):12018-32. PubMed ID: 26311781
[TBL] [Abstract][Full Text] [Related]
3. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
4. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Williams JL; Patel JR; Daniels BP; Klein RS
J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
6. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
[TBL] [Abstract][Full Text] [Related]
8. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
[TBL] [Abstract][Full Text] [Related]
9. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
10. Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?
Chen CZ; Neumann B; Förster S; Franklin RJM
Open Biol; 2021 Jan; 11(1):200352. PubMed ID: 33497588
[TBL] [Abstract][Full Text] [Related]
11. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
12. The link between excitotoxic oligodendroglial death and demyelinating diseases.
Matute C; Alberdi E; Domercq M; Pérez-Cerdá F; Pérez-Samartín A; Sánchez-Gómez MV
Trends Neurosci; 2001 Apr; 24(4):224-30. PubMed ID: 11250007
[TBL] [Abstract][Full Text] [Related]
13. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus.
Bergles DE; Roberts JD; Somogyi P; Jahr CE
Nature; 2000 May; 405(6783):187-91. PubMed ID: 10821275
[TBL] [Abstract][Full Text] [Related]
15. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Syed YA; Zhao C; Mahad D; Möbius W; Altmann F; Foss F; González GA; Sentürk A; Acker-Palmer A; Lubec G; Lilley K; Franklin RJM; Nave KA; Kotter MRN
Acta Neuropathol; 2016 Feb; 131(2):281-298. PubMed ID: 26687980
[TBL] [Abstract][Full Text] [Related]
17. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Cui QL; Kuhlmann T; Miron VE; Leong SY; Fang J; Gris P; Kennedy TE; Almazan G; Antel J
Am J Pathol; 2013 Aug; 183(2):516-25. PubMed ID: 23746653
[TBL] [Abstract][Full Text] [Related]
18. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Boyd A; Zhang H; Williams A
Acta Neuropathol; 2013 Jun; 125(6):841-59. PubMed ID: 23595275
[TBL] [Abstract][Full Text] [Related]
19. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
20. Revisiting Notch in remyelination of multiple sclerosis lesions.
Brosnan CF; John GR
J Clin Invest; 2009 Jan; 119(1):10-3. PubMed ID: 19104146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
